军事知识服务平台
急性肾损伤尿液生物标志物的检测及应用进展
Detection and application progress of urinary biomarkers in acute kidney injury
摘要 急性肾损伤(AKI)是一种常见的临床综合征,病情变化迅速,早期识别和干预对改善预后至关重要。血清肌酐和尿量是改善全球肾脏病预后组织(KDIGO)指南AKI 诊断中的主要指标,尿沉渣评分是AKI早期发现、病因鉴别以及预后判断的参考,多种标志物的临床应用提高了AKI诊断的敏感度和特异度。随着分子生物学理论与技术在临床检验诊断中的应用进展,AKI相关尿液生物标志物逐渐受到关注,陆续被应用于AKI早期发现、诊断、病因鉴别。
Abstract:
Acute kidney injury (AKI) is a common clinical syndrome characterized by rapidly changing condition, and early recognition and intervention are crucial for improving patient outcomes. Serum creatinine and urine output are the main indicators for AKI diagnosis according to the kidney disease:improving global outcomes (KDIGO) guidelines. Urinary sediment scoring serves as a reference for early detection of AKI, etiological differentiation, and prognosis assessment. The clinical application of multiple biomarkers has improved the sensitivity and specificity of AKI diagnosis. With advances in molecular biology theories and technologies in clinical laboratory diagnostics, urinary biomarkers for AKI have increasingly attracted attention and have been gradually applied for early detection, diagnosis, and etiological differentiation of AKI.
刊 名 中华检验医学杂志 ISTICPKU
年,卷(期): 2026, 49(10)
在线出版日期: 2026年10月19日